Send feedback

CAPN3 p.Ser443Pro

c.1327T>C · rs1595834751 · VCV662490

Likely pathogenic Expert panel
Classification
Likely pathogenic
ClinVar
Review
Expert panel ★★★☆
ClinVar · 8 submitters
AlphaMissense
likely pathogenic
0.9878 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00017%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
autosomal recessive limb-girdle muscular dystrophy

ClinGen expert panel — Limb Girdle Muscular Dystrophy VCEP

Likely Pathogenic for autosomal recessive limb-girdle muscular dystrophy. Applied ACMG criteria (verbatim):

PP4_Moderate PM2_Supporting PM3_Strong PP3

Curation rationale (ClinGen, verbatim)

The NM_000070.3: c.1327T>C variant in CAPN3 is a missense variant predicted to cause substitution of serine with proline at amino acid position 443, p.(Ser443Pro). This variant has been detected in at least six unrelated individuals with LGMD, where it was identified in unconfirmed phase with two unique pathogenic variants (c.1505T>C p.(Thr501Ile), 0.5 pts x3, PMID: 35135626, 26810512, 39258114; c.1746-20C>G, 0.5 pts x3, GRASP-LGMD Consortium, ClinVar SCV000960844.6 internal data communication) (PM3_Strong). At least one patient with this variant and a second CAPN3 variant displayed progressive limb girdle muscle weakness and significantly reduced calpain-3 protein expression, which is specific for CAPN3-related LGMD (PMID: 35135626, 26810512; PP4_Moderate). The Grpmax variant allele frequency in gnomAD v.4.1.1 is 0.000001698 in the European (non-Finnish) population (2/1177684 chromosomes) (PM2_Supporting). The computational predictor REVEL gives a score of 0.896, which is above the LGMD VCEP threshold of ≥0.70, evidence that correlates with impact to CAPN3 function (PP3). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (specifications v2.0.0; 04/29/2026): PM3_Strong, PP4_Moderate, PM2_Supporting, PP3.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.9878likely pathogenic ✓ concordant with ClinVar · top 9% in CAPN3
REVEL0.896moderately pathogenic-leaning
SaProtLLR -12.37damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 6.1GERP 1.7, phastCons 1
Regional constrainto/e 0.96unconstrained · MANE · 52 kb · p 0.21 · regional, not allelic
Overall
CADD25.1PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00017% European (non-Finnish) · 2/1,177,684 alleles
Filtering AF 2.8e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.1e-05%
Overall 0.000137% 2/1,457,334 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CAPN3
Protein
p.Ser443Pro
Coding
c.1327T>C
MANE Select
NM_000070
dbSNP
rs1595834751
Type
single nucleotide variant
Location
chr15:42399625 (GRCh38)
Gene constraint
LOEUF 0.896 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 79.18 · 5 PDB
Residue 443
the 'domain iii' region
Full CAPN3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/capn3-p-ser443pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown